Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PTN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 10.16M
December 31, 2025 14.48M
September 30, 2025 1.273M
June 30, 2025 2.564M
March 31, 2025 2.520M
December 31, 2024 3.417M
September 30, 2024 2.384M
June 30, 2024 9.527M
March 31, 2024 10.01M
December 31, 2023 9.485M
September 30, 2023 5.525M
June 30, 2023 10.98M
March 31, 2023 19.63M
December 31, 2022 21.18M
September 30, 2022 21.19M
June 30, 2022 29.94M
March 31, 2022 37.72M
December 31, 2021 47.33M
September 30, 2021 53.42M
June 30, 2021 60.10M
March 31, 2021 68.64M
December 31, 2020 72.16M
September 30, 2020 86.59M
June 30, 2020 82.85M
March 31, 2020 88.95M
Date Value
December 31, 2019 91.46M
September 30, 2019 96.70M
June 30, 2019 43.51M
March 31, 2019 19.81M
December 31, 2018 24.66M
September 30, 2018 32.62M
June 30, 2018 38.00M
March 31, 2018 25.74M
December 31, 2017 34.96M
September 30, 2017 39.96M
June 30, 2017 40.45M
March 31, 2017 55.43M
December 31, 2016 13.49M
September 30, 2016 10.25M
June 30, 2016 9.383M
March 31, 2016 23.15M
December 31, 2015 33.37M
September 30, 2015 47.52M
June 30, 2015 27.30M
March 31, 2015 36.73M
December 31, 2014 42.69M
September 30, 2014 17.79M
June 30, 2014 12.18M
March 31, 2014 16.72M
December 31, 2013 18.18M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Decoy Therapeutics, Inc. 8.289M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B
Anika Therapeutics, Inc. 38.41M
Savara, Inc. 173.03M